Biontech Se (BNTX) Directors and Executive Officers - CSIMarket
CSIMarket
 
Biontech Se  (NASDAQ: BNTX)

Biontech Se

Officers & Directors


1. Ugur Sahin - CEO and Co-founder: Dr. Ugur Sahin is a Turkish-German immunologist and oncology researcher. He received his medical training at the Universities of Cologne and Zurich and holds a Ph.D. in medicine from the University of Cologne. Dr. Sahin founded BioNTech SE in 2008 with his wife, Dr. ezlem Tereci.

2. ezlem Tereci - Chief Medical Officer and Co-founder: Dr. ezlem Tereci is a Turkish-German physician-scientist specializing in immunology and oncology. She received her medical degree from the University of Essen and her Ph.D. in immunology from the University of Homburg. Dr. Tereci co-founded BioNTech SE with her husband, Dr. Ugur Sahin, in 2008.

3. Sean Marett - Chief Business and Commercial Officer: Sean Marett has been with BioNTech SE since 2011 and served as the Chief Operating Officer before being appointed Chief Business and Commercial Officer. He has over 25 years of experience in the pharmaceutical industry and previously held various senior positions at Merck KGaA.

4. Sierk Poetting - Chief Financial Officer: Sierk Poetting joined BioNTech SE in 2014 and has since then held the position of Chief Financial Officer. He has over 15 years of experience in corporate finance and previously worked at Merck KGaA, Deutsche Bank, and Citibank.

5. Ozan Oncel - Senior Vice President, Global Operations and Supply Chain: Ozan Oncel joined BioNTech SE in 2015 and is responsible for the company's global operations and supply chain. He has nearly two decades of experience in senior operational roles in the pharmaceutical industry and previously worked at Pfizer.

6. Ozlem Futerman - Vice President, Legal: Ozlem Futerman joined BioNTech SE in 2015 and is responsible for the company's legal affairs. She has extensive legal experience from private practice and has previously worked at leading law firms, including White & Case and Clifford Chance.

Helmut Jeggle - Chairman of the Supervisory Board: Helmut Jeggle has been the Chairman of BioNTech SE's Supervisory Board since 2018. He has over 30 years of experience in the pharmaceutical industry and previously held various senior positions at Merck KGaA.



Biontech Se currently has 7807 employees.






BNTX Management Effectiveness BNTX Revenue per Employee BNTX Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.